WASHINGTON (AP) — WASHINGTON (AP) — Vanda Pharmaceuticals Inc. (VNDA) on Thursday reported a loss of $4.9 million in its fourth quarter.
On a per-share basis, the Washington-based company said it had a loss of 8 cents.
The biopharmaceutical company posted revenue of $53.2 million in the period.
For the year, the company reported a loss of $18.9 million, or 33 cents per share. Revenue was reported as $198.8 million.
Vanda expects full-year revenue in the range of $210 million to $250 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
